Achim joined the Results Healthcare team in 2015. Achim has a BSc in
biochemistry from the University of Birmingham and completed a Ph.D.
looking at the identification and culture of prostate cancer stem cells
from University College London. He also spent a brief period at Bayer
Healthcare, working on process development and optimization in biologics
manufacturing. Since joining Results, he has worked on a variety of
transactions across the healthcare sector, including the sale of Leukine® by
Sanofi to Partner Therapeutics, the acquisition of Kent Pharmaceuticals by
Duke Street Capital, SK Biotek’s acquisition of BMS’ Swords manufacturing,
and investment by SEP in Dotmatics.